• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰非皮肤性黑色素瘤的流行病学。

Epidemiology of extracutaneous melanoma in the Netherlands.

机构信息

Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1453-9. doi: 10.1158/1055-9965.EPI-09-1267. Epub 2010 May 25.

DOI:10.1158/1055-9965.EPI-09-1267
PMID:20501769
Abstract

BACKGROUND

Reliable population-based incidence and survival data on extracutaneous melanoma (ECM) are sparse.

METHODS

Incidence data (1989-2006) from the Netherlands Cancer Registry were combined with vital status on January 1, 2008. Age-adjusted annual incidence rates were calculated by direct standardization, and the estimated annual percentage change was estimated to detect changing trends in incidence. Additionally, we carried out cohort-based relative survival analysis.

RESULTS

Ocular melanomas were the most common ECM subsite with European standardized incidence rates (ESR) of 10.7 and 8.2 per 1,000,000 person-years for males and females, respectively. In comparison, for cutaneous melanoma (CM), the ESRs for men and women were 122 and 155 per million person-years, respectively. No statistically significant trends in the incidence of ECM were detected, whereas an annual increase of 4.4% for men and 3.6% for women was detected in the incidence of CM. Relative survival for ECM was poor, but differed largely between anatomic subtypes ranging from a 5-year relative survival of 74% for ocular melanomas to 15% for certain subsites of mucosal melanomas.

CONCLUSIONS

Of all ECM subsites, ocular melanomas had the highest incidence and the best survival. Mucosal melanomas were the second most frequent subsite of ECM. Five-year relative survival for all ECM subtypes was worse if compared with CM. No statistically significant trends in the incidence of (subsites of) ECM were determined.

IMPACT

This study gives insight into the relative sizes of the different subgroups of ECM as well as an estimate of 5-year survival, which varies substantially by subsite.

摘要

背景

有关皮肤外黑色素瘤(ECM)的可靠基于人群的发病率和生存数据较为匮乏。

方法

我们将荷兰癌症登记处(1989-2006 年)的发病率数据与截至 2008 年 1 月 1 日的生存状况相结合。通过直接标准化计算年龄调整后的年发病率,并估计年度百分比变化,以检测发病率变化趋势。此外,我们还进行了基于队列的相对生存分析。

结果

眼部黑色素瘤是最常见的 ECM 亚部位,男性和女性的欧洲标准化发病率(ESR)分别为每 100 万人年 10.7 和 8.2。相比之下,皮肤黑色素瘤(CM)的男性和女性 ESR 分别为每百万人口 122 和 155。未检测到 ECM 发病率的统计学显著趋势,而 CM 的发病率则分别检测到男性和女性每年增加 4.4%和 3.6%。ECM 的相对生存率较差,但在解剖亚部位之间差异很大,从眼部黑色素瘤的 5 年相对生存率 74%到某些黏膜黑色素瘤亚部位的 15%不等。

结论

在所有 ECM 亚部位中,眼部黑色素瘤的发病率最高,生存率最好。黏膜黑色素瘤是 ECM 的第二大亚部位。与 CM 相比,所有 ECM 亚型的 5 年相对生存率更差。未确定 ECM(亚部位)发病率的统计学显著趋势。

影响

本研究深入了解了 ECM 的不同亚组的相对大小以及 5 年生存率的估计值,后者因亚部位而异。

相似文献

1
Epidemiology of extracutaneous melanoma in the Netherlands.荷兰非皮肤性黑色素瘤的流行病学。
Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1453-9. doi: 10.1158/1055-9965.EPI-09-1267. Epub 2010 May 25.
2
Incidence of noncutaneous melanomas in the U.S.美国非皮肤黑色素瘤的发病率
Cancer. 2005 Mar 1;103(5):1000-7. doi: 10.1002/cncr.20866.
3
Invasive cutaneous melanoma in The Netherlands, 1989-1990.1989 - 1990年荷兰的侵袭性皮肤黑色素瘤
Eur J Cancer Prev. 1996 Feb;5(1):69-74.
4
A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).基于人群的加拿大艾伯塔省皮肤黑色素瘤研究(1993-2002 年)。
J Am Acad Dermatol. 2010 Feb;62(2):227-32. doi: 10.1016/j.jaad.2009.01.047. Epub 2009 Dec 16.
5
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.德国南部皮肤黑色素瘤的发病率和死亡率:1976年至2003年按解剖部位和病理特征划分的趋势
Cancer. 2006 Sep 15;107(6):1331-9. doi: 10.1002/cncr.22126.
6
Cancer in adolescents and young adults (15-29 years): a population-based study in the Netherlands 1989-2009.青少年和青年期癌症(15-29 岁):荷兰 1989-2009 年的基于人群的研究。
Acta Oncol. 2012 Sep;51(7):922-33. doi: 10.3109/0284186X.2012.705891. Epub 2012 Aug 30.
7
Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.1956年至2005年50年间加拿大中部皮肤恶性黑色素瘤的发病率及解剖学表现
J Am Acad Dermatol. 2009 Jul;61(1):44-50. doi: 10.1016/j.jaad.2009.01.020. Epub 2009 Apr 23.
8
Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.荷兰皮肤鳞状细胞癌的趋势:发病率上升,但相对生存率和死亡率稳定 1989-2008。
Eur J Cancer. 2012 Sep;48(13):2046-53. doi: 10.1016/j.ejca.2012.01.003. Epub 2012 Feb 16.
9
Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.立陶宛侵袭性皮肤黑色素瘤的发病率、死亡率及相对生存率的时间趋势。
Eur J Cancer. 2006 Mar;42(5):660-7. doi: 10.1016/j.ejca.2005.11.027. Epub 2006 Feb 28.
10
Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.1982 - 2002年澳大利亚昆士兰州原位和侵袭性黑色素瘤的发病趋势。
Cancer Causes Control. 2006 Feb;17(1):21-7. doi: 10.1007/s10552-005-3637-4.

引用本文的文献

1
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma.黏膜黑色素瘤免疫微环境的多样性及其对检查点抑制剂免疫治疗的反应。
JCI Insight. 2024 Nov 8;9(21):e179982. doi: 10.1172/jci.insight.179982.
2
Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990-2019).荷兰1496例黏膜黑色素瘤患者的发病率及生存率趋势(1990 - 2019年)
Cancers (Basel). 2023 Feb 28;15(5):1541. doi: 10.3390/cancers15051541.
3
Successful treatment with avapritinib in patient with mucosal metastatic melanoma.
阿伐替尼成功治疗黏膜转移性黑色素瘤患者。
Ther Adv Med Oncol. 2020 Jul 31;12:1758835920946158. doi: 10.1177/1758835920946158. eCollection 2020.
4
Uveal Melanoma: A Review of the Literature.葡萄膜黑色素瘤:文献综述
Oncol Ther. 2018 Jun;6(1):87-104. doi: 10.1007/s40487-018-0056-8. Epub 2018 Feb 6.
5
Primary Melanoma: from History to Actual Debates.原发性黑素瘤:从历史到当前的争议。
Curr Oncol Rep. 2019 Dec 19;21(12):112. doi: 10.1007/s11912-019-0843-x.
6
Predictors of mucosal melanoma survival in a population-based setting.基于人群的黏膜黑色素瘤生存预测因素。
J Am Acad Dermatol. 2019 Jul;81(1):136-142.e2. doi: 10.1016/j.jaad.2018.09.054. Epub 2018 Oct 5.
7
Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.黏膜黑色素瘤患者的临床情况、预后及新治疗选择:75例患者的回顾性分析
Medicine (Baltimore). 2017 Jan;96(1):e5753. doi: 10.1097/MD.0000000000005753.
8
Mucosal melanomas in the racially diverse population of California.加利福尼亚种族多样化人群中的黏膜黑色素瘤。
J Am Acad Dermatol. 2017 Feb;76(2):250-257. doi: 10.1016/j.jaad.2016.08.007. Epub 2016 Oct 11.
9
Inflammation and macrophage polarization in cutaneous melanoma: Histopathological and immunohistochemical study.皮肤黑色素瘤中的炎症与巨噬细胞极化:组织病理学和免疫组织化学研究
Int J Immunopathol Pharmacol. 2016 Dec;29(4):715-719. doi: 10.1177/0394632016650895. Epub 2016 Jul 7.
10
Melanoma of the oral cavity: pathogenesis, dermoscopy, clinical features, staging and management.口腔黑色素瘤:发病机制、皮肤镜检查、临床特征、分期及治疗
J Dermatol Case Rep. 2014 Sep 30;8(3):60-6. doi: 10.3315/jdcr.2014.1175.